Schedule 13G ownership disclosure

COGENT BIOSCIENCES INC

Common Stock, par value $0.001 per share · CUSIP: 19240Q201

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Point72 Asset Management, L.P.

    Shares: 9,986,132.00 · Class: 8.7%

  • Point72 Capital Advisors, Inc.

    Shares: 9,986,132.00 · Class: 8.7%

  • Steven A. Cohen

    Shares: 9,986,132.00 · Class: 8.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-001038
Form type
SCHEDULE 13G/A
Filer
Cogent Biosciences, Inc.
CIK
CIK 1622229
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub